On this page
What is Subungual Melanoma (Nail Tumor)?
Nails serve an important dual function: they protect the sensitive tips of our fingers and toes, and they enable specific fine motor movements such as scratching, gripping, and picking up small objects. The hard, visible portion of the nail is called the nail plate (or nail lamina). It appears pink because of the blood flowing through the dermis beneath it, the nail bed. However, if separated from the nail bed, its natural yellowish color becomes apparent.
The nail plate itself contains no living cells, which is why cutting nails causes no pain.
Like all structures of the body, nails can be affected by malignant tumors. One such tumor is subungual melanoma, a form of cancer closely related to cutaneous (skin) melanoma but significantly rarer. It is important to emphasize upfront that the discovery of a colored stripe on the nail is only rarely a sign of cancer; however, any new or changing pigmentation of the nail should be evaluated by a dermatologist.
Causes
Subungual melanoma is a subtype of malignant cutaneous melanoma that originates from the structures within the nail apparatus. Like all melanomas, it arises from melanocytes, which are specialized pigment-producing cells found in the epidermis. These cells are responsible for skin color and tanning responses.
However, unlike most cutaneous melanomas, subungual melanoma does not appear to be directly caused by sun (UV) exposure. The nail unit is largely protected from ultraviolet radiation, and epidemiological data does not support a strong correlation between sun exposure and the development of this tumor.
Key epidemiological features include:
- Possible association with direct trauma to the nail unit, as noted by several authors (DermNet NZ), though a causal relationship has not been definitively established.
- Age of onset: More common after the age of 70 in men and after 60 in women.
- Most commonly affected digits: The big toe (hallux) and thumb (pollex) are the most frequently involved, followed by the index finger.
- Racial distribution: Subungual melanoma accounts for a disproportionately higher percentage of all melanomas in individuals with darker skin types (e.g., people of African, Asian, or Hispanic descent), in whom cutaneous melanoma from UV exposure is less common.
Symptoms
Subungual melanoma typically presents as a characteristic change in the color of the nail bed, appearing as a brown or black discoloration. This may take the form of:
- A longitudinal melanonychia: A vertical stripe or band of pigmentation running the length of the nail plate, which is the most classic presentation.
- An irregularly shaped pigmented area with uneven borders.
An important anatomical note: what is visible externally is not the tumor itself, but the pigment produced by it. The melanoma originates in the nail matrix (the tissue beneath the base of the nail that generates the nail plate), and the pigment migrates outward with nail growth. This explains why the base of the pigmented band is typically wider than its distal end: as the nail plate progressively pushes the pigment forward toward the fingertip.
Progressive Changes
As the tumor grows, additional nail changes may develop over time:
- Nail thickening
- Splitting, crumbling, or destruction of the nail plate
- Pain beneath or around the nail
- Ulceration and bleeding
- Nodule formation or other structural deformities of the nail unit
Amelanotic (Non-Pigmented) Subungual Melanoma
Less commonly, subungual melanoma may present in an amelanotic form, meaning it produces little or no visible pigment. In these cases, the main findings are:
- Nail dystrophy: Structural abnormality of the nail without obvious discoloration.
- An atypical band that slowly increases in both length and width.
Amelanotic subungual melanoma is particularly challenging to diagnose because it lacks the telltale dark pigmentation, and may be mistaken for benign nail conditions.
Differential Diagnosis: Other Causes of Nail Pigmentation
It is essential to consider other causes of nail pigmentation before reaching a diagnosis of melanoma. These include:
- Subungual hematoma: Bleeding under the nail, typically caused by direct trauma (e.g., a crushing injury or repetitive pressure from ill-fitting shoes). Unlike melanoma, a hematoma is gradually pushed forward and outward as the nail grows, eventually disappearing entirely.
- Melanonychia: Pigmentation of the nail from a variety of benign causes, including medications, systemic diseases, or physiological variation. This is particularly common in individuals with darker skin.
- Onychomycosis: Fungal infection of the nail that can cause discoloration (often yellow, white, or brown), thickening, and distortion of the nail plate.
A thorough history, including any history of trauma or nail infections, is therefore essential to avoid unnecessary alarm or, conversely, to avoid missing a true malignancy.
When to See a Doctor
Any new or changing discoloration of the nail should be evaluated by a dermatologist, particularly if it appears suddenly, grows over time, or is associated with other changes such as pain or nail destruction.
As a general guiding principle (BC Cancer Agency):
- The appearance of multiple pigmented stripes across several nails is generally less concerning and more likely to reflect a benign cause (e.g., physiological melanonychia, especially in individuals with darker skin).
- The development of a single pigmented band, particularly in a fair-skinned individual, warrants prompt dermatological evaluation.
- Rapid growth of a pigmented lesion is more characteristic of malignancy than the slow, stable appearance of benign nevi.
Do not delay seeking medical advice if:
- A dark stripe under a nail has appeared without obvious cause (e.g., no preceding trauma)
- A pre-existing pigmented band is widening, darkening, or developing irregular borders
- The pigmentation appears to spread onto the skin around the nail (the cuticle or periungual skin)
- The nail is becoming painful, deformed, or is bleeding without injury
Diagnosis
Diagnosis of subungual melanoma is made by a dermatologist through a stepwise approach:
1. Detailed Medical History (Anamnesis)
The clinician will gather information including:
- Family history of melanoma or other skin cancers
- Personal history of melanoma, numerous moles, or previous skin cancer
- History of trauma to the affected nail (to assess whether a hematoma could explain the findings)
- Age and skin phototype (fair skin increases concern)
- Rate of change of the pigmented lesion
2. Clinical and Dermoscopic Examination
Visual examination is performed with the naked eye and, crucially, with dermoscopy (dermatoscopy), a non-invasive technique. This method uses a handheld optical instrument equipped with a magnifying lens and a polarized light source, allowing detailed visualization of subsurface nail and skin structures that are not visible to the naked eye.
Dermoscopy can reveal features strongly suggestive of melanoma, such as irregular pigment distribution, micro-Hutchinson’s sign, and atypical vascular patterns.
3. The ABCDEF Rule for Nail Pigmentation
Levit et al. (PubMed) described an ABCDEF rule adapted specifically for evaluating pigmented nail lesions. This is analogous to the classic ABCDE rule used for cutaneous melanoma:
| Letter | Criterion | Details |
|---|---|---|
| A | Age | Peak incidence between 50–70 years of age |
| B | Brown-black band | Width >3 mm, with irregular or blurred borders |
| C | Change | Increasing size, width, or rate of growth of the band |
| D | Digit | Most commonly affects thumb, big toe, or index finger |
| E | Extension | Pigmentation extending to the surrounding periungual skin (Hutchinson’s sign) |
| F | Family history | Personal or family history of melanoma |
Hutchinson’s sign, the extension of dark pigmentation from under the nail to the surrounding skin of the nail fold or cuticle, is a particularly important warning sign highly suggestive of subungual melanoma.
4. Biopsy
When clinical and dermoscopic findings raise sufficient concern, a biopsy is performed: a small sample of tissue is removed from the nail matrix or nail bed and sent for histopathological examination under a microscope. This provides the definitive diagnosis and allows staging of the tumor.
Survival Rates
The prognosis of subungual melanoma is strongly correlated with the stage of disease at the time of diagnosis. Early detection offers the best chance of cure. The following 5-year and 10-year survival rates are based on melanoma staging data (note that stage-specific data for subungual melanoma specifically may vary; these figures reflect overall melanoma staging benchmarks):
| Stage | 5-Year Survival | 10-Year Survival |
|---|---|---|
| IA | ~97% | ~95% |
| IB | ~92% | ~86% |
| IIA | ~81% | ~67% |
| IIB | ~70% | ~57% |
| IIC | ~53% | ~40% |
| IIIA | ~78% | ~68% |
| IIIB | ~59% | ~43% |
| IIIC | ~40% | ~24% |
| IV | 15–20% | 10–15% |
For Stage IV (distant metastases), outcomes are more favorable when:
- Spread is limited to distant skin or lymph nodes rather than visceral organs (lung, liver, brain).
- Serum lactate dehydrogenase (LDH) levels are within the normal range. Elevated LDH is associated with higher tumor burden and poorer prognosis.
These figures highlight the critical importance of early diagnosis: a Stage IA melanoma carries a 5-year survival rate approaching 97%, compared to just 15–20% for Stage IV disease. Any suspicious nail change should therefore be evaluated without delay.
Treatment
Surgical Excision: The Cornerstone of Treatment
The primary treatment for subungual melanoma is complete surgical excision of the tumor. In many cases, the initial biopsy itself constitutes the first step of surgical management.
Historically, treatment almost universally required amputation of the affected digit. However, more conservative surgical approaches have been increasingly adopted in recent years for early-stage tumors, aiming to preserve function and cosmesis while achieving adequate oncological margins. The extent of surgery depends on:
- Tumor thickness (Breslow depth)
- Location within the nail unit
- Stage of the disease at diagnosis
Lymph Node Evaluation
Following histological confirmation of the diagnosis, assessment of the regional lymph nodes is mandatory. This is typically performed via:
- Sentinel lymph node biopsy (SLNB): A minimally invasive procedure to identify and sample the first lymph node(s) draining the tumor site, allowing detection of metastatic spread at an early stage.
- Imaging studies (CT, PET-CT, MRI) to evaluate for distant metastases.
Additional Therapies
In selected cases, particularly for advanced-stage disease or high-risk tumors, additional treatments may be employed:
- Radiotherapy: May be used as adjuvant therapy following surgery, particularly when complete surgical margins are difficult to achieve.
- Immunotherapy: Checkpoint inhibitors (such as anti-PD-1 agents: pembrolizumab, nivolumab) have revolutionized the treatment of advanced melanoma and are now a cornerstone of therapy for Stage III and IV disease.
- Targeted therapy: For melanomas harboring specific genetic mutations (e.g., BRAF V600E mutation), targeted molecular therapies (BRAF and MEK inhibitors) may be indicated.
- Chemotherapy: Less commonly used for melanoma in the current era of immunotherapy and targeted therapy, but may be considered in specific clinical scenarios.
Follow-Up
Following treatment, regular dermatological follow-up is essential to:
- Monitor for local recurrence
- Detect new primary melanomas early
- Assess regional lymph nodes and systemic health
- Provide psychosocial support
Sources and Bibliography
- American Cancer Society – Nail Changes
- Subungual Melanoma – Rosalind J. Mole; Duncan N. MacKenzie – StatPearls, NCBI
- DermNet NZ – Melanoma of the Nail Unit
- Levit EK et al. – The ABC Rule for Clinical Detection of Subungual Melanoma – PubMed
- NCBI – Subungual Melanoma Image Gallery
- BC Cancer Agency – Subungual Melanoma: Early Diagnosis
